Dabigatran versus warfarin in patients with atrial fibrillation.
Poller
Leon
L
Jespersen
Joergen
J
Ibrahim
Saied
S
D000367:Age Factors; D000925:Anticoagulants / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000401:mortality; D001562:Benzimidazoles / Q000008:administration & dosage*; D000069604:Dabigatran; D004617:Embolism / Q000453:epidemiology; D006470:Hemorrhage / Q000139:chemically induced / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D019934:International Normalized Ratio; D011725:Pyridines / Q000008:administration & dosage*; D020521:Stroke / Q000453:epidemiology; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D001562:Benzimidazoles; D011725:Pyridines; D014859:Warfarin; D000069604:Dabigatran